Antipain-induced suppression of oncogene expression in H-ras-transformed NIH3T3 cells
1Institute of Environmental Medicine, New York University Medical Center, New York 10016.
Abstract:
Antipain (AP; 50 micrograms/ml) inhibits transformation of NIH3T3 cells after transfection with an activated H-ras oncogene. To determine whether AP effects on transformation are associated with alterations in oncogene expression, NIH3T3 cells were cotransfected with an activated H-ras oncogene and the selectable marker gene aph, and gene expression was quantified. Fifty percent of geneticin-resistant colonies which were exposed to AP failed to express the transformed phenotype as determined by their inability to grow in soft agar. Northern blot analysis of the transformed and nontransformed colonies revealed that suppression of H-ras transformation by AP was associated with a decrease in expression of the exogenously transfected H-ras gene by approximately 4-fold. Expression of the endogenous oncogene c-myc was decreased by approximately 2.5-fold, to levels seen in untransfected cells. AP-treated colonies that retained the transformed phenotype had levels of oncogene expression that were similar to untreated ras-transformed colonies. Southern blot analysis revealed no effects of AP on incorporation or copy number of the H-ras gene.
Insights
Antipain (AP) suppresses H-ras oncogene-induced cell transformation by reducing expression of both transfected and endogenous oncogenes. This inhibition of oncogene expression is linked to the loss of the transformed cell phenotype.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Cell transformation is a critical step in cancer development.
- Oncogenes, such as H-ras, play a key role in driving cellular transformation.
- Investigating compounds that can modulate oncogene expression is crucial for cancer research.
Purpose of the Study:
- To investigate the effect of Antipain (AP) on H-ras oncogene-induced NIH3T3 cell transformation.
- To determine if AP's inhibitory effect on transformation is mediated by alterations in oncogene expression.
- To quantify changes in both exogenous H-ras and endogenous c-myc expression.
Main Methods:
- NIH3T3 cells were co-transfected with an activated H-ras oncogene and a selectable marker gene (aph).
- Cells were treated with Antipain (AP) at 50 micrograms/ml.
- Gene expression was quantified using Northern blot analysis.
- Cellular transformation was assessed by the ability to grow in soft agar.
- Southern blot analysis was performed to assess gene incorporation and copy number.
Main Results:
- Antipain (AP) inhibited the transformed phenotype in 50% of geneticin-resistant colonies.
- AP treatment led to a 4-fold decrease in the expression of the transfected H-ras gene.
- Expression of the endogenous c-myc oncogene decreased by approximately 2.5-fold in AP-treated cells.
- AP did not affect the incorporation or copy number of the H-ras gene, as shown by Southern blot analysis.
Conclusions:
- Antipain (AP) effectively suppresses H-ras-mediated NIH3T3 cell transformation.
- The anti-transformation effect of AP is associated with decreased expression of both exogenous H-ras and endogenous c-myc.
- AP's mechanism of action does not involve alterations in the H-ras gene's integration or copy number.
More Related Videos
07:16Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor (LATS) Biosensor
Published on: September 13, 2018
09:32Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
Published on: October 17, 2025
Related Concept Videos
Abnormal Proliferation
The Ras Gene
Ras is a superfamily...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
